• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
 
Generic Name:  2-(3,7-Dimethyl-octa-2, 6-dienyl)—6-ethylamino-3-hydroxy-5-pentyl-[1,4]benzoquinone
Date Designated:  02/01/2018
Orphan Designation:  Treatment of Huntington’s Disease (HD)
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Emerald Health Pharmaceuticals Inc.
5820 Nancy Ridge Drive
San Diego, California 92121
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-